Library Item Posts on Medivizor
Navigation Menu

Library Item Posts on Medivizor

Adapted resistance training improves freezing of gait in patients with Parkinson’s disease

Adapted resistance training improves freezing of gait in patients with Parkinson’s disease

Posted by on Jul 6, 2020 in Parkinson's Disease | 0 comments

In a nutshell This study investigated whether resistance training improves freezing of gait (FOG) severity in patients with Parkinson's disease (PD). Researchers suggested that adapted resistance training significantly improves the outcomes of FOG. Some background Parkinson's disease (PD) is a chronic disorder that affects the brain. Brain...

Read More

The effects of cholesterol-lowering drugs on breast cancer relapse in postmenopausal women under aromatase inhibitor treatment

The effects of cholesterol-lowering drugs on breast cancer relapse in postmenopausal women under aromatase inhibitor treatment

Posted by on Jul 5, 2020 in Breast cancer | 0 comments

In a nutshell The study evaluated the link between statin (cholesterol-lowering drugs) use and risks of breast cancer (BC) relapse under adjuvant aromatase inhibitors (AI) therapy in women after their menopause. The main finding was that statin use was related with lower risks of BC relapse in such patients. Some background Women with...

Read More

Does insulin glargine-300 reduce the risk of hypoglycemia in patients with type 1 diabetes?

Does insulin glargine-300 reduce the risk of hypoglycemia in patients with type 1 diabetes?

Posted by on Jul 5, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared the risk of severe hypoglycemia (dangerously low blood glucose levels) with insulin glargine-100 (Lantus) and insulin glargine-300 (Toujeo) for patients with type 1 diabetes (T1D). It found that both medications improved glucose control, and insulin glargine-300 had a lower risk of hypoglycemia. Some background T1D is...

Read More

Comparing laparoscopic ovarian drilling and medication to induce ovulation in women with polycystic ovarian syndrome

Comparing laparoscopic ovarian drilling and medication to induce ovulation in women with polycystic ovarian syndrome

Posted by on Jul 5, 2020 in Infertility | 0 comments

In a nutshell This study investigated laparoscopic ovarian drilling (LOD) compared to medical ovulation induction (MOI) in women with polycystic ovarian syndrome (PCOS).  They found that LOD was associated with decreased live birth rates (LBR) when compared with MOI. Some background Polycystic ovarian syndrome (PCOS) is a common condition. It is...

Read More

Managing patients with limited-stage Hodgkin lymphoma by brentuximab vedotin based therapy

Managing patients with limited-stage Hodgkin lymphoma by brentuximab vedotin based therapy

Posted by on Jul 5, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell The study evaluated if brentuximab-vedotin (BV; Adcetris) consolidation therapy can reduce the use of radiation therapy (RT) in patients with limited-stage (LS) Hodgkin lymphoma (HL). The authors found that BV consolidation achieved good outcomes in such patients when given after ABVD therapy. Some background HL is a cancer of the...

Read More

The impact of a pharmaceutical care program for patients with B-cell lymphoma treated with ibrutinib

The impact of a pharmaceutical care program for patients with B-cell lymphoma treated with ibrutinib

Posted by on Jul 5, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study aimed to investigate the impact of a pharmaceutical care program on the safety and effectiveness of ibrutinib in patients with B-cell non-Hodgkin's lymphoma (NHL). This study concluded that the management of ibrutinib treatment by using a pharmaceutical care program results in improved survival and better tolerance than...

Read More

The impact of a pharmaceutical care program for patients with chronic lymphocytic leukemia treated with ibrutinib

The impact of a pharmaceutical care program for patients with chronic lymphocytic leukemia treated with ibrutinib

Posted by on Jul 5, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the impact of a pharmaceutical care program on the safety and effectiveness of ibrutinib in patients with chronic lymphocytic leukemia. This study concluded that management of ibrutinib treatment by using a pharmaceutical care program results in improved survival and better...

Read More